News
-
Oxeltis appoints director of chemistry and consultant in medicinal chemistry to deliver new development strategy
Dr Stéphane Salamone and Dr Olivier Lavergne will be instrumental in boosting additional lab and medchem capabilities at the company…
-
Sars-Cov 2 and business continuity at Oxeltis
At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our…
-
Tokyo (Japan) – medicinal chemistry symposium, nov 27-29, 2019
For the second year, Oxeltis is participating to the Medicinal Chemistry Symposium organized by the Pharmaceutical Society of Japan. Please…
-
R&D tax credit, 2020-2024 accreditation
Oxeltis is pleased to announce to its customers and R&D partners the renewal of its agreement for R&D tax credit…
-
20th SCI/RSC Medicinal Chemistry Symposium
Meet Oxeltis in Cambridge (UK), Sept 8-11, 2019, at the 20th SCI / RSC Medicinal Chemistry Symposium, Europe’s premier biennial…
-
Chem outsourcing – New Jersey-USA (Sept 17-19, 2019)
Meet Oxeltis for Medicinal chemistry FTE services and FFS custom synthesis at ChemOutsourcing in Parsippany (NJ) very soon… ChemOutsourcing is…
-
BioPharm America, Boston Sept 11-12, 2019
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia…
-
Afssi Connexions 2019, Lyon le 2 et 3 juillet
Retrouvez Oxeltis aux Afssi Connexions 2019 à Lyon! contact@oxeltis.com
-
Oxeltis at Eurocarb 2019 – Leiden (NL) June 30 – July 04
Meet oxeltis’ scientists at Eurocarb 2019! The symposium aims to bring together all those working in the glycosciences, bridging chemistry…
SEARCH
Services